Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: The Phase III POSEIDON Study.

Details

Language :

English

ISSN :

0732183X

Volume :

41

Issue :

6

Database :

Supplemental Index

Journal :

Journal of Clinical Oncology

Publication Type :

Academic Journal

Accession number :

161906938

Full Text :

https://doi.org/10.1200/JCO.22.00975